Skip to content

Sinem Fethiye Karipcin, MD

NPI 1114194933ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· New York, NY

Obstetrics & Gynecology, Reproductive Endocrinology (MD) in New York, New York, licensed in NY, FL, CA and TX, with an NPI issued in May 2008. Part D covered 12 prescriptions written in 2024. Ferring Pharmaceuticals Inc. reported $47.30 in payments in 2025, mostly food and beverage.

Overview

NPI1114194933
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 12, 2008
Last updated in NPPESAug 14, 2026
Certified by providerAug 14, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)12 · 30 30-day fills
Total drug cost$2,601

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$47.30 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$47.302

What the 2025 payments were for

  • Food and Beverage$47.30 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in New York

All 153 Obstetrics & Gynecology, Reproductive Endocrinology providers in New York · All Obstetrics & Gynecology, Reproductive Endocrinology providers in New York